Welcome to the Ypsomed Blog

Stay informed with expert insights on digital selfcare, connected drug delivery, and the future of self-medication. The Ypsomed blog is your go-to source for trends, innovations, and thought leadership in the evolving healthcare landscape.

MIDBA: A new regulatory approach to clinical device bridging

The development of drug-device combination products continues to evolve, with increasing attention on how clinical bridging between different delivery systems is handled. In this context, regulatory approaches that support more efficient and …

Biobased plastics in drug delivery: From material equivalence to systemic decarbonization

Biobased plastics can cut carbon without changing performance or regulatory status. In our latest blog, Nadine Kaufmann and Michael Schori explore how material equivalence, lifecycle thinking, and scale enable real decarbonization in drug delivery …

Interview: Enhancing Clinical Trials with CliniPilot and Clear to Clinic Programme

In this exclusive interview, Dr Carolina Canapè and Roger Lüscher talk with ONdrugDelivery’s Guy Furness about the application of connectivity in decentralised trials, and how Ypsomed’s CliniPilot and the company’s range of clinic-ready autoinjectors …

The compass for innovation: Regulatory Affairs at Ypsomed

Acting as the compass for innovation, Ypsomed’s regulatory strategy steers ideas through development to deliver safe, compliant solutions to patients worldwide.

Self-injection device manufacturing in a dynamic world

How did pen-inspired injectors evolve into today’s flexible self-injection platforms? Discover the trends in usability, scale-up, and resilient manufacturing that are shaping the future of drug delivery in a fast-changing industry landscape.

Optimizing high-dose delivery

Subcutaneous injection or high-dose formulations requires optimized solutions. This joint article by Ypsomed and BD explores how YpsoMate 2.25 and BD Neopak™ syringes perform across a range of viscosities.

Sustainable GLP-1 drug delivery

GLP-1 therapies are entering a high-growth phase, driving demand for scalable, sustainable delivery solutions. As formulations evolve, device usability, and environmental impact becomes a key industry challenge.

Automated assembly for fast-track design verification of YpsoMate platforms

Discover how Ypsomed’s innovative in-house assembly system streamlines workflows, enhances precision and slashes verification times, helping customers bring their products to market with speed and confidence.

Advancing large-volume subcutaneous drug delivery

What are the latest trends in large-volume drug delivery? A recent study explores key developments, while Ypsomed’s innovative injection platforms address the challenges of large volumes and high viscosities with patient-friendly solutions.